Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1507) 1507
female (1361) 1361
science & technology (1297) 1297
life sciences & biomedicine (1281) 1281
selective estrogen receptor modulators - therapeutic use (856) 856
selective estrogen receptor modulators - adverse effects (567) 567
middle aged (553) 553
biological and medical sciences (409) 409
aged (402) 402
medical sciences (377) 377
breast cancer (363) 363
animals (352) 352
selective estrogen receptor modulators - pharmacology (352) 352
raloxifene hydrochloride - therapeutic use (322) 322
tamoxifen - therapeutic use (319) 319
breast neoplasms - drug therapy (317) 317
estrogen (312) 312
tamoxifen (303) 303
osteoporosis (290) 290
obstetrics & gynecology (282) 282
oncology (272) 272
tamoxifen - adverse effects (271) 271
raloxifene (267) 267
risk factors (263) 263
adult (257) 257
postmenopause (252) 252
pharmacology & pharmacy (251) 251
selective estrogen receptor modulators (250) 250
menopause (246) 246
selective estrogen receptor modulators - administration & dosage (233) 233
breast neoplasms - prevention & control (228) 228
treatment outcome (213) 213
male (206) 206
raloxifene hydrochloride - adverse effects (203) 203
osteoporosis, postmenopausal - drug therapy (202) 202
endocrinology & metabolism (191) 191
estrogens (187) 187
pharmacology. drug treatments (182) 182
medicine & public health (164) 164
postmenopausal women (162) 162
abridged index medicus (161) 161
selective estrogen receptor modulator (158) 158
drug therapy (156) 156
health aspects (156) 156
care and treatment (153) 153
double-blind method (152) 152
hormone replacement therapy (147) 147
randomized controlled trials as topic (143) 143
antineoplastic agents, hormonal - therapeutic use (141) 141
cancer (141) 141
internal medicine (141) 141
raloxifene hydrochloride - pharmacology (141) 141
gynecology. andrology. obstetrics (137) 137
osteoporosis, postmenopausal - prevention & control (135) 135
research (125) 125
antineoplastic agents, hormonal - adverse effects (123) 123
bone density - drug effects (123) 123
estrogen replacement therapy - adverse effects (123) 123
prevention (123) 123
bone density conservation agents - therapeutic use (122) 122
clinical trials as topic (122) 122
general & internal medicine (117) 117
medicine, general & internal (117) 117
tumors (116) 116
breast neoplasms - pathology (110) 110
aged, 80 and over (109) 109
risk assessment (107) 107
women (107) 107
osteoporosis - drug therapy (106) 106
tamoxifen - pharmacology (103) 103
analysis (102) 102
diphosphonates - therapeutic use (100) 100
dose-response relationship, drug (99) 99
bazedoxifene (97) 97
aromatase inhibitors - therapeutic use (96) 96
receptors, estrogen - metabolism (94) 94
raloxifene hydrochloride - administration & dosage (92) 92
clinical trials (90) 90
tamoxifen - administration & dosage (88) 88
estrogen replacement therapy (87) 87
estrogen receptors (83) 83
bone density (82) 82
womens health (82) 82
rats (80) 80
endometrium - drug effects (78) 78
fractures (76) 76
serm (75) 75
aromatase inhibitors (74) 74
obstetrics and gynecology (73) 73
quality of life (73) 73
time factors (73) 73
chemotherapy (72) 72
hormone therapy (72) 72
tamoxifen - analogs & derivatives (72) 72
breast neoplasms - epidemiology (70) 70
chemotherapy, adjuvant (70) 70
estrogens - therapeutic use (70) 70
review (68) 68
fractures, bone - prevention & control (67) 67
indoles - adverse effects (67) 67
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1719) 1719
Japanese (47) 47
French (22) 22
German (16) 16
Spanish (12) 12
Danish (5) 5
Polish (5) 5
Portuguese (5) 5
Dutch (4) 4
Italian (4) 4
Russian (4) 4
Hungarian (3) 3
Arabic (1) 1
Chinese (1) 1
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Estrogen action, selective estrogen receptor modulators, and women's health
: progress and promise
by Jordan, V. Craig (Virgil Craig)
2013, ISBN 9781848169579, xxxvi, 507
Women's Health | Receptors, Estrogen | Estrogens | pharmacology | physiology | Estrogen Receptor Modulators | Selective estrogen receptor modulators
Book
Details down arrow
2. Full Text A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER+/HER2- advanced breast cancer
by Hamilton, Erika P and Patel, Manish R and Armstrong, Anne C and Baird, Richard D and Jhaveri, Komal and Hoch, Matthias and Klinowska, Teresa and Lindemann, Justin P.O and Morgan, Shethah R and Schiavon, Gaia and Weir, Hazel M and Im, Seock-Ah
Clinical cancer research, ISSN 1078-0432, 08/2018, Volume 24, Issue 15, pp. 3510 - 3518
Life Sciences & Biomedicine | Oncology | Science & Technology | Nausea - chemically induced | Receptor, ErbB-2 - genetics | Cinnamates - administration & dosage | Humans | Middle Aged | Selective Estrogen Receptor Modulators - adverse effects | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Drug-Related Side Effects and Adverse Reactions - pathology | Dose-Response Relationship, Drug | Aged, 80 and over | Adult | Female | Selective Estrogen Receptor Modulators - administration & dosage | Breast Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Indoles - adverse effects | Breast Neoplasms - pathology | Breast Neoplasms - blood | Cinnamates - adverse effects | Aged | Biomarkers, Tumor - genetics | Nausea - pathology | Drug-Related Side Effects and Adverse Reactions - classification | Tumor markers | Toxicity | Liver | Estrogens | Estrogen receptors | Diarrhea | Fatigue | Mass spectroscopy | Nausea | Breast cancer | Pharmacology | Patients | ErbB-2 protein | Anticancer properties | Safety engineering | Antitumor activity | Safety | Solid tumors | Mass spectrometry | Cancer | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Selective estrogen receptor modulators: Tissue specificity and clinical utility
by Martinkovich, Stephen and Shah, Darshan and Planey, Sonia Lobo and Arnott, John A
Clinical interventions in aging, ISSN 1176-9092, 09/2014, Volume 9, pp. 1437 - 1452
SERMs | Estrogen receptors | Selective estrogen receptor modulators | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Selective Estrogen Receptor Modulators - adverse effects | Female | Selective Estrogen Receptor Modulators - therapeutic use | Organ Specificity | Humans | Chronic diseases | Receptors | Pharmacology, Experimental | Health aspects | Risk factors | Estrogen | Disease prevention | Osteoporosis | Endometrial cancer | Metabolites | Womens health | Genes | Estrogens | Ligands | Breast cancer | Deoxyribonucleic acid--DNA | Index Medicus | selective estrogen receptor modulators | estrogen receptors | Selective Estrogen Receptor Modulators
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice
by Maximov, Philipp Y and Lee, Theresa M and Craig Jordan, V
Current clinical pharmacology, ISSN 1574-8847, 2013, Volume 8, Issue 2, pp. 135 - 155
Arzoxifene | Ospemifene | Selective estrogen receptor modulator | Bazedoxifene | Lasofoxifene | Raloxifene | Tamoxifen | Humans | Selective Estrogen Receptor Modulators - adverse effects | Osteoporosis, Postmenopausal - pathology | Clinical Trials as Topic | Breast Neoplasms - drug therapy | Drug Discovery | Osteoporosis, Postmenopausal - drug therapy | Animals | Selective Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - pathology | Drug Design | Female | Osteoporosis, Postmenopausal - prevention & control | Selective Estrogen Receptor Modulators - pharmacology
Journal Article
Details down arrow
5. Full Text Selective estrogen receptor modulators in clinical practice: a safety overview
by Ellis, Amanda J and Hendrick, Vicky M and Williams, Robert and Komm, Barry S
Expert opinion on drug safety, ISSN 1474-0338, 06/2015, Volume 14, Issue 6, pp. 921 - 934
bazedoxifene | fulvestrant | safety | toremifene | selective estrogen receptor modulator | raloxifene | lasofoxifene | ospemifene | tamoxifen | Ospemifene | Selective estrogen receptor modulator | Bazedoxifene | Lasofoxifene | Toremifene | Raloxifene | Safety | Tamoxifen | Fulvestrant | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Dyspareunia - drug therapy | Humans | Selective Estrogen Receptor Modulators - adverse effects | Estrogens - adverse effects | Breast Neoplasms - drug therapy | Osteoporosis, Postmenopausal - drug therapy | Estrogens - therapeutic use | Patient Selection | Estrogen Antagonists - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Estrogen Antagonists - adverse effects | Female | Drug Monitoring | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: Current State of Development
by Gennari, Luigi and Merlotti, Daniela and Valleggi, Fabrizio and Martini, Giuseppe and Nuti, Ranuccio
Drugs & aging, ISSN 1170-229X, 2007, Volume 24, Issue 5, pp. 361 - 379
Arzoxifene | Ospemifene | Bazedoxifene | Lasofoxifene | Toremifene | Raloxifene | Postmenopausal osteoporosis | Selective estrogen receptor modulators | Tamoxifen | Research and development | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Osteoporosis. Osteomalacia. Paget disease | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Receptors, Estrogen - metabolism | Bone Density | Humans | Osteoporosis, Postmenopausal - metabolism | Selective Estrogen Receptor Modulators - adverse effects | Selective Estrogen Receptor Modulators - chemistry | Selective Estrogen Receptor Modulators - administration & dosage | Clinical Trials as Topic | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Selective Estrogen Receptor Modulators - therapeutic use | Lipids - blood | Female | Aged | Molecular Structure | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
by Jordan, V. Craig
Journal of medicinal chemistry, ISSN 0022-2623, 03/2003, Volume 46, Issue 7, pp. 1081 - 1111
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Hormones. Endocrine system | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Chemical agents | Carcinogenesis, carcinogens and anticarcinogens | Medical sciences | Antineoplastic agents | Tumors | Raloxifene Hydrochloride - adverse effects | Raloxifene Hydrochloride - pharmacology | Raloxifene Hydrochloride - therapeutic use | Estradiol Congeners - adverse effects | Humans | Endometrial Neoplasms - chemically induced | Antineoplastic Agents - therapeutic use | Structure-Activity Relationship | Estrogen Receptor Modulators - therapeutic use | Estrogen Receptor alpha | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents - adverse effects | Female | Steroids - pharmacology | Antineoplastic Agents - pharmacology | Steroids - therapeutic use | Osteoporosis, Postmenopausal - prevention & control | Drug Resistance | Steroids - chemistry | Estrogen Receptor Modulators - chemistry | Models, Molecular | Selective Estrogen Receptor Modulators - chemistry | Estrogen Receptor Modulators - pharmacology | Receptors, Estrogen - drug effects | Animals | Tamoxifen - therapeutic use | Tamoxifen - pharmacology | Tamoxifen - analogs & derivatives | Tamoxifen - adverse effects | Estrogen Receptor beta | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Beyond estrogen: advances in tissue selective estrogen complexes and selective estrogen receptor modulators
by Pinkerton, J. V and Conner, E. A
Climacteric : the journal of the International Menopause Society, ISSN 1369-7137, 03/2019, Volume 22, Issue 2, pp. 140 - 147
tissue selective estrogen complex | estetrol | bazedoxifene | raloxifene | Selective estrogen receptor modulators | conjugated estrogens | tamoxifen | bazedoxifene/conjugated estrogens | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Hot Flashes - drug therapy | Raloxifene Hydrochloride - therapeutic use | Vagina - drug effects | Estrogens, Conjugated (USP) - administration & dosage | Humans | Middle Aged | Selective Estrogen Receptor Modulators - adverse effects | Breast Neoplasms - drug therapy | Indoles - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Breast Neoplasms - prevention & control | Female Urogenital Diseases - drug therapy | Indoles - adverse effects | Selective Estrogen Receptor Modulators - therapeutic use | Tamoxifen - therapeutic use | Atrophy - prevention & control | Postmenopause | Adult | Female | Aged | Estrogens, Conjugated (USP) - adverse effects | Vagina - pathology | Hormone replacement therapy | Breast cancer | Hyperplasia | Estrogens | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights